Tougher in vitro diagnostic (IVD) Directive safeguards finally win over the cautious French
This article was originally published in Clinica
After years of debate, the French authorities now appear satisfied with new manufacturing controls which are to be introduced for high-risk products under the proposed In Vitro Diagnostics Directive. The controls, known as Common Technical Specifications (CTSs), respond to French demands for more stringent requirements for high-risk IVDs than were originally envisaged in the directive.
You may also be interested in...
The maker of prestige-inspired cosmetics at value prices follows its TikTok viral success by teaming with Kathleen Belsten, aka Loserfruit, the second most-followed female gamer on the Amazon-owned livestreaming platform Twitch.
As distribution of Regeneron’s monoclonal antibody treatment for coronavirus begins, OWS officials worry about provider confusion with Lilly’s product due to differences in preparation and administration.
Join us for a brief audio tour around the past week's key developments in the global biopharma industry, in this podcast version of Scrip's Five Must-Know Things.